Fueling Innovation: Public Programs Driving Drug Discovery


12 October, 2017 - 13 October, 2017

Description: The focus of the second collaboration between ASPET and the Academic Drug Discovery Consortium (ADDC) will explore a critical domain to innovation how to obtain funding.

Pharmaceutical companies have steadily decreased their research ranks for years. Recognizing a potential crisis in the making, governments have responded to the evolving R&D landscape by creating new mechanisms to fund research focused on identifying novel therapies for untreated patients. This phenomenon has occurred on a national scale and at the level of individual states and even some metropolitan regions now have funding instruments. A single investment can trigger the invention of a new treatment, support the education of the next generation of scientists and build economies in meaningful and lasting ways.

If you are interested in academic drug discovery and would like to build your network of collaborators, learn firsthand how other scientists have successfully developed their programs and explore the funding options available to launch and sustain a treatment discovery program, you will want to attend.


Sponsors include: MilliporeSigma,Eli Lilly,Pfizer,Janssen Research & Development,Waters Corporation

Registration Webpage

Registration Deadline: 28 September, 2017

Contact Name: Matthew Hartman

Contact E-mail: mhartman@addconsortium.org

Organization Website

Organizer: ASPET, ADDC

Event Website

Cost Range: $0-$125

Event Sponsors: Millipore Sigma, Eli Lilly, PFizer, Janssen Research & Development, Waters Corporation

Address:
45 Center Drive
Bethesda,Maryland
United States